Results 191 to 200 of about 36,520 (265)

Comparison of VEGF level in tears post phacoemulsification between non-proliferative diabetic retinopathy and non-diabetic patients. [PDF]

J Diabetes Metab Disord, 2021
Azhan A, Zunaina E, Mahaneem M, Siti-Azrin AH.   +3 more
europepmc   +1 more source

Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric‐Onset Type 1 Diabetes—A Cross‐Sectional Analysis From the Diabetes Prospective Follow‐Up Registry DPV

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4194-4204, May 2026.
ABSTRACT Aims Cardiovascular disease (CVD) is a major contributor to premature morbidity and mortality in individuals with type 1 diabetes (T1DM). Glycaemic control often deteriorates during the transition from paediatric to adult care, and thus we assessed the prevalence and pharmacological management of overt and actionable modifiable cardiovascular ...
Alena Welters, Christina Reinauer, Karl Otfried Schwab, Claudia Boettcher, Melanie Hess, Heike Bartelt, Axel Dost, Joachim Rosenbauer, Angela Galler, Reinhard W. Holl   +9 more
wiley   +1 more source

Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England. [PDF]

Eye (Lond), 2022
Nevill CR, Stratton IM, Maruti SS, Massó-González EL, Sivaprasad S, Bailey C, Ehrlich M, Chong V, Scanlon PH.   +8 more
europepmc   +1 more source

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4335-4343, May 2026.
ABSTRACT Background Type 1 diabetes (T1D) and overweight/obesity (OW) are chronic conditions impairing health‐related quality of life (HRQoL). While diabetes primarily affects psychosocial domains, OW impacts physical functioning and social stigma. Despite the increasing prevalence of OW among individuals with T1D, their combined effect on HRQoL has ...
Renata Risi, Domiziana Pauletto, Valeria Zanghi Buffi, Valentina Berna, Andrea Carafa, Federica Barbaro, Francesco De Vita, Luca D'Onofrio, Rocco Amendolara, Angelo Lauria Pantano, Alessandra Di Flaviani, Simona Zampetti, Dario Tuccinardi, Raffaella Buzzetti, Ernesto Maddaloni, on behalf of the AD_OWOB study group   +15 more
wiley   +1 more source

Downregulation of MerTK in circulating T cells of patients with non-proliferative diabetic retinopathy. [PDF]

Front Endocrinol (Lausanne)
Bu S, Ling JY, Wu X, Zhang L, Shi X, Huang L, Zhao Z, Yang Y, Xiang Z, Liu YU, Liu Y, Zhang Y.   +11 more
europepmc   +1 more source

Effects of Ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene. [PDF]

BMJ Open Diabetes Res Care, 2021
Liu Z, Jiang H, Townsend JH, Wang J.
europepmc   +1 more source

P 339 EOG changes in non-proliferative and proliferative diabetic retinopathy

Vision Research, 1995
Tzekov, R., Tanev, V.
openaire   +1 more source

Attenuation of Oxygen‐Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG‐2 With an Antibody

Genes to Cells, Volume 31, Issue 3, May 2026.
The effects of intraocular administration of neutralizing antibodies against VEGFA, ANG‐2, or bispecific to these two factors on pathological findings were examined in the oxygen‐induced retinopathy (OIR) mouse model. The antibody to VEGFA or ANG‐2 attenuated oxygen‐induced neovascularization and inflammation, and the bispecific antibody more ...
Hirokazu Oohashi, Toshiro Iwagawa, Hiroto Abe, Chihiro Kawaji, Yuta Inokuchi, Tetsuhiro Soeda, Kosuke Saita, Makoto Aihara, Sumiko Watanabe   +8 more
wiley   +1 more source

Ultrasound super-resolution imaging and shear wave elastography for the non-invasive diagnosis of non-proliferative diabetic retinopathy: a pilot study. [PDF]

Quant Imaging Med Surg
Zhang Y, Zhou Y, Chen T, Huang X, Hu Y, Zhou Q, Deng Q.   +6 more
europepmc   +1 more source

Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR). [PDF]

Diabetes Obes Metab, 2023
Rossing P, Garweg JG, Anker SD, Osonoi T, Pitt B, Rosas SE, Ruilope LM, Zhu D, Brinker M, Finis D, Leal S, Schmelter T, Bakris G.   +12 more
europepmc   +1 more source